A high-grade glioma with SOS1 hamplification

被引:1
|
作者
Vidal, Barbara [1 ,6 ]
Bryke, Christine [1 ,6 ]
Hsu, Nancy [1 ,6 ]
Alterman, Ronnie [2 ,6 ]
Yeo, Alan T. [4 ,5 ]
Charest, Al [3 ,4 ,6 ]
Varma, Hemant [1 ,6 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA
[3] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[4] Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA
[5] Tufts Univ, Sch Med, Sackler Sch Grad Studies, Boston, MA 02111 USA
[6] Harvard Med Sch, Boston, MA 02115 USA
关键词
SOS1; glioma; glioneuronal tumor; TERT amplification; array CGH; GENE; MUTATION;
D O I
10.5414/NP301182
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The molecular alterations underlying progression of low-grade glial/glioneuronal tumors remain to be elucidated. We present a case of a 56-year-old male with an enhancing left temporal lobe tumor. Histology revealed a high-grade glioma adjacent to a low-grade glioneuronal component with abundant Rosenthal fibers, focal eosinophilic granular bodies, and CD34-positive neurons. The tumor was negative for IDH1 (R132H), BRAF-V600E, and the KIAA1549-BRAF fusion. Comparative genomic hybridization detected a large amplification (> 15 copies) of the Son of Sevenless 1 (SOS1) gene, a component of the MAPK pathway. Although activating mutations in the MAPK pathway occur frequently in gliomas and glioneuronal tumors, SOS1 gene amplification has not been reported previously. This case indicates another potential mechanism for MAPK activation in glial tumors.
引用
收藏
页码:126 / 134
页数:9
相关论文
共 50 条
  • [21] Gene Therapy for High-Grade Glioma
    Iwami, Ken-ichiro
    Natsume, Atsushi
    Wakabayashi, Toshihiko
    NEUROLOGIA MEDICO-CHIRURGICA, 2010, 50 (09) : 727 - 736
  • [22] Updates in the management of high-grade glioma
    David Bradley
    Jeremy Rees
    Journal of Neurology, 2014, 261 : 651 - 654
  • [23] Bevacizumab for the treatment of high-grade glioma
    Khasraw, Mustafa
    Simeonovic, Marcelle
    Grommes, Christian
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (08) : 1101 - 1111
  • [24] Bevacizumab at recurrence in high-grade glioma
    Andrea Salmaggi
    Paola Gaviani
    Andrea Botturi
    Elena Lamperti
    Giorgia Simonetti
    Daniela Ferrari
    Antonio Silvani
    Neurological Sciences, 2011, 32 : 251 - 253
  • [25] Temozolomide for recurrent high-grade glioma
    Macdonald, DR
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 3 - 12
  • [26] Antiangiogenic therapies for high-grade glioma
    Andrew D. Norden
    Jan Drappatz
    Patrick Y. Wen
    Nature Reviews Neurology, 2009, 5 : 610 - 620
  • [27] Healthcare Costs for High-grade Glioma
    Liu, Yang
    Tyler, Evan
    Lustick, Martin
    Klein, David
    Walter, Kevin A.
    ANTICANCER RESEARCH, 2019, 39 (03) : 1375 - 1381
  • [28] Cognition in survivors of high-grade glioma
    Cairncross, JG
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (09) : 3210 - 3211
  • [29] Cellular immunotherapy for high-grade glioma
    Chow, Kevin K. H.
    Gottschalk, Stephen
    IMMUNOTHERAPY, 2011, 3 (03) : 423 - 434
  • [30] Different etiology in familial low-grade glioma and high-grade glioma?
    Malmer, BS
    Henriksson, R
    Gronberg, H
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 385 - 385